<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The recently detected reciprocal translocations in <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloic leucemia (<z:mp ids='MP_0005481'>CML</z:mp>) and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) made it necessary to clarify if <z:hpo ids='HP_0002858'>meningiomas</z:hpo> really show the described <z:mp ids='MP_0004026'>monosomy</z:mp> 22 or also a translocation </plain></SENT>
<SENT sid="1" pm="."><plain>In 10 out of 12 <z:hpo ids='HP_0002858'>meningiomas</z:hpo> a total or partial translocation of the missing chromosome 22 to another chromosome could be ruled out by fluorescence banding analysis </plain></SENT>
<SENT sid="2" pm="."><plain>Two <z:hpo ids='HP_0002858'>meningiomas</z:hpo> showed marker chromosomes of such a complex composition that it was impossible to decide if a 22 translocation was present or not </plain></SENT>
<SENT sid="3" pm="."><plain>From these results it was concluded that <z:hpo ids='HP_0002858'>meningioma</z:hpo> cells, in contrast to <z:mp ids='MP_0005481'>CML</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, show almost regularly a loss of a definitive part of their genome </plain></SENT>
</text></document>